LNSR Logo

LENSAR, Inc. (LNSR) 

NASDAQ$14.12-0.01 (-0.07%)
Market Cap
$166.6M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
355 of 917
Rank in Industry
45 of 118

LNSR Insider Trading Activity

LNSR Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$23,97910100
Sells
$000

Related Transactions

Winer Gary Mdirector10$23,9790$0$23,979

About LENSAR, Inc.

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.

Insider Activity of LENSAR, Inc.

Over the last 12 months, insiders at LENSAR, Inc. have bought $23,979 and sold $0 worth of LENSAR, Inc. stock.

On average, over the past 5 years, insiders at LENSAR, Inc. have bought $76,158 and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Winer Gary M (director) — $23,979.

The last purchase of 685 shares for transaction amount of $3,083 was made by Winer Gary M (director) on 2024‑09‑03.

List of Insider Buy and Sell Transactions, LENSAR, Inc.

2024-09-03PurchaseWiner Gary Mdirector
685
0.0057%
$4.50$3,083+65.77%
2024-08-28PurchaseWiner Gary Mdirector
1,000
0.0082%
$4.45$4,450+63.60%
2024-08-27PurchaseWiner Gary Mdirector
500
0.0042%
$4.50$2,250+64.30%
2024-08-26PurchaseWiner Gary Mdirector
802
0.007%
$4.58$3,673+67.91%
2024-08-22PurchaseWiner Gary Mdirector
2
<0.0001%
$4.30$9+72.05%
2024-08-21PurchaseWiner Gary Mdirector
500
0.0043%
$4.35$2,176+68.97%
2024-08-20PurchaseWiner Gary Mdirector
500
0.0045%
$4.20$2,100+86.45%
2024-08-16PurchaseWiner Gary Mdirector
6
<0.0001%
$4.03$24+72.77%
2024-08-14PurchaseWiner Gary Mdirector
1,000
0.0087%
$4.20$4,200+88.28%
2024-08-12PurchaseWiner Gary Mdirector
500
0.0042%
$4.03$2,015+78.01%
2023-11-22PurchaseWiner Gary Mdirector
300
0.0024%
$2.10$630+86.32%
2023-11-16PurchaseWiner Gary Mdirector
1,000
0.0088%
$2.13$2,125+105.24%
2023-11-15PurchaseWiner Gary Mdirector
500
0.0044%
$2.15$1,075+104.03%
2023-11-10PurchaseWiner Gary Mdirector
1,000
0.0083%
$2.13$2,135+88.11%
2023-08-11PurchaseWiner Gary Mdirector
705
0.0063%
$3.60$2,538-3.75%
2023-08-10PurchaseWiner Gary Mdirector
1,000
0.0089%
$3.66$3,660-5.96%
2023-05-22PurchaseWEISNER AIMEE Sdirector
16,647
0.1515%
$2.75$45,779+18.09%
2023-05-19PurchaseWEISNER AIMEE Sdirector
22,153
0.2133%
$2.59$57,376+32.27%
2023-05-18PurchaseWEISNER AIMEE Sdirector
7,700
0.071%
$2.61$20,097+25.76%
2023-05-17PurchaseWEISNER AIMEE Sdirector
3,500
0.0316%
$2.29$8,015+39.87%
Total: 28
*Gray background shows transactions not older than one year

Insider Historical Profitability

18.49%
Winer Gary Mdirector
80840
0.6856%
$1.14M210+22.03%
PDL BIOPHARMA, INC.10 percent owner
8667397
73.5123%
$122.47M10<0.0001%
STAAB THOMAS R IIChief Financial Officer
135131
1.1461%
$1.91M20<0.0001%
WEISNER AIMEE Sdirector
54285
0.4604%
$767,047.0540+29%
*Gray background shows insiders who have made transactions during last year

LNSR Institutional Investors: Active Positions

Increased Positions20+58.82%190,808+5.01%
Decreased Positions10-29.41%357,688-9.38%
New Positions8New53,534New
Sold Out Positions0Sold Out0Sold Out
Total Postitions44+29.41%4M-4.38%

LNSR Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Park West Asset Management Llc$12,014.006.76%810,676-179,269-18.11%2024-12-31
Dimensional Fund Advisors Lp$9,105.005.12%614,384-34,575-5.33%2024-12-31
Brandes Investment Partners, Lp$7,252.004.08%489,318+45,920+10.36%2024-12-31
Vanguard Group Inc$6,424.003.61%433,47400%2024-12-31
Renaissance Technologies Llc$5,171.002.91%348,891+40,946+13.3%2024-12-31
Dcf Advisers, Llc$3,409.001.92%230,055-10,545-4.38%2024-12-31
Blackrock, Inc.$2,541.001.43%171,484+17,169+11.13%2024-12-31
Geode Capital Management, Llc$1,572.000.88%106,058+5,627+5.6%2024-12-31
Clearline Capital Lp$825.000.46%55,652-117,352-67.83%2024-12-31
Rbf Capital, Llc$742.000.42%50,07400%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.